Canadian Heart Failure Society

Name

Canadian Heart Failure Society

Legal name

Canadian Heart Failure Society

Website

https://heartfailure.ca

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Medical Professional Society Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Heart Failure & Transplant Cardiology (HLAKABAD)

akta.pro secondary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

Keywords

• Heart failure guidelines
• Continuing medical education
• Professional medical society
• Clinical guidelines publishing
• Cardiology education programs

Headquarters

HQ city

Ottawa

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Membership Dues: Annual membership fees for healthcare professionals, scientists, educators, and heart failure specialists. Membership provides access to conferences, education programs, research competitions, and member-only resources.
2. Conference Fees: Revenue from HF Update annual congress and CCCS congress with discounted member rates and standard registration fees.
3. Educational Programs: Accredited continuing medical education programs available to members, with some programs possibly funded by pharmaceutical partners.
4. Industry Partnerships: Educational grants and sponsorships from pharmaceutical companies including Novartis Canada, AstraZeneca, Bayer, Pfizer, Boehringer Ingelheim, Eli Lilly for guideline development and education programs.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

The Canadian Heart Failure Society (CHFS) operates as a nonprofit professional medical society that delivers accredited continuing medical education, publishes Canadian heart failure clinical guidelines, hosts the HF Update congress, runs research competitions, and produces patient education resources. Its portfolio centers on clinical guideline development (CCS/CHFS Heart Failure Guidelines), accredited self-assessment programs (HF21, New Frontiers in Reducing CVD Risk), an annual congress (HF Update), research awards, and bilingual patient-facing tools (medication guides, patient diaries, symptom questionnaires).

Product overview

The Canadian Heart Failure Society (CHFS) is a professional medical society, not a traditional technology product company. CHFS operates as an Affiliate Society of the Canadian Cardiovascular Society (CCS) and serves as the national voice for Canadian heart failure specialists. The organization's core offerings consist of accredited continuing medical education programs, clinical practice guidelines, patient education resources, research competitions, and an annual congress (HF Update). The portfolio includes guideline publications (CCS-CHFS Guidelines), accredited self-assessment programs (HF21, New Frontiers), patient-facing resources (Patient Diary, Medication Guide, Amyloid Questionnaires), awareness campaigns (Heart Failure Awareness Week), research award programs, and professional education tools (SGLT2i Algorithm, Heart to Heart podcast series). These offerings function as a unified educational ecosystem rather than a modular software platform, designed to improve heart failure care through research, advocacy, education, and development of best practices.

Differentiator

Problem solved

Functional benefit

Brands

• HF Update: Canada's largest biennial heart failure congress bringing together clinicians and researchers.
• HF21 Program
• The New HFrontier
• Heart to Heart (Cœur à cœur)

Products and services

• Heart Failure Update Congress Canada's largest annual meeting on the rapidly evolving field of heart failure, featuring accredited learning activities, joint sessions with international societies, and presentations by Canadian HF experts.
• HF21 Program Virtual webinar series providing Canadian perspective and case-based approach on the 2021 CHFS/CCS HF Guidelines, consisting of 21 episodes of approximately 21 minutes each.
• New Frontiers In Reducing CVD Risk 2025 Section 3 Accredited Self-Assessment Program available through CHFS Member Portal, focusing on reducing cardiovascular disease risk.
• The New HFrontier Webinar series addressing clinical challenges in worsening heart failure and TTR amyloidosis, featuring Canadian HF experts discussing new data, treatments, and clinical recommendations.
• CCS-CHFS 2025 Guideline Update 2025 guideline update for pharmacologic management of heart failure with nonreduced ejection fraction (LVEF > 40%), providing recommendations for HFnrEF treatment.
• Heart to Heart Podcast Series Podcast series featuring interviews with Canadian HF experts discussing innovative initiatives and protocols for improving heart failure patient outcomes.
• SGLT2i Algorithm Two-page resource providing an algorithm for sodium-glucose cotransporter-2 inhibitors for prevention and treatment of cardiomyopathies and cardiovascular diseases.
• Heart Failure Guidelines & Clinical Updates Comprehensive collection of CCS/CHFS heart failure guidelines including annual updates from 2003 to present, covering diagnosis, treatment, and management recommendations.
• Heart Failure Medications: A Patient & Caregiver Guide First-of-its-kind patient guide on heart failure medications, developed with cardiovascular specialists and patient organizations, featuring tools, videos, and infographics.
• Heart Failure Management Tools Patient-facing tools including symptom questionnaires, fluid and sodium intake guidance documents, and educational video series for heart failure management.
• CHFS Patient Diary Patient diary developed in collaboration with patients to help track symptoms and recognize early signs of decompensation, recommended for daily use and follow-up appointments.
• Amyloid Patient Questionnaires Screening questionnaires for cardiac amyloidosis produced by the Calgary Amyloid Program and approved by CHFS, including cardiomyopathy, neuropathy, and patient questionnaires.
• Heart Failure Awareness Week Annual awareness campaign (May 3-9, 2026) providing tools, resources, and educational materials for public, healthcare providers, and patients to raise awareness about heart failure.
• Research Competitions Annual research competitions including RCTC/CHFS Research Competition and HF Update Trainee Research Competition, recognizing exceptional research in heart failure, transplant, and mechanical circulatory support.
• Annual Achievement Award Annual award established in 2016 to honor members whose contribution to heart failure as academic, researcher, or clinician is outstanding.

Quantifiable outcome

• More than 90,000 Canadians diagnosed with heart failure annually - CHFS guidelines help standardize care across Canada
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

16 partnerships are on record, tiered core, major and minor.

• Canadian Cardiovascular Society (CCS)coreStrategic or Co-development PartnerCCS is the parent organization of CHFS. The CCS manages CHFS membership, congresses, and provides infrastructure support. CHFS is an Affiliate Society of CCS. Joint guideline development (CCS/CHFS Heart Failure Guidelines) and research competitions are conducted together.
• Heart and Stroke FoundationcoreStrategic or Co-development PartnerCollaborative partner for Heart Failure Awareness Week campaign and patient education resources. Joint webinar presented with HeartLife Foundation and Heart and Stroke on heart failure care continuity.
• HeartLife FoundationcoreStrategic or Co-development PartnerPatient organization partner for heart failure awareness and education. Collaborated on patient medication guide development and awareness week activities.
• Canadian Council of Cardiovascular Nurses (CCCN)majorChannel Partner/ Reseller/ DistributorJoint membership offering with 20% discount for nurses. Collaborative webinars on heart failure management topics for nurses.
• Ted Rogers Centre for Heart ResearchmajorStrategic or Co-development PartnerPartner organization for heart failure awareness week and patient education. Contributed to patient medication guide development.
• Heart Failure Society of America (HFSA)majorStrategic or Co-development PartnerInternational partner for heart failure education. Joint sessions at HF Update congress. Members receive 50% reduction in HFSA membership fees.
• European Society of CardiologymajorStrategic or Co-development PartnerInternational partner with joint sessions at HF Update congress. Collaboration on guideline development and education.
• Research Canada / RCTCmajorStrategic or Co-development PartnerJoint research competition (RCTC/CHFS) recognizing exceptional research in heart failure, transplantation, and mechanical circulatory support.
• Novartis CanadaminorOthersPharmaceutical sponsor for education programs including HF21 series, patient education videos, and accredited education programs.
• AstraZenecaminorOthersPharmaceutical sponsor for SGLT2i algorithm development and practical approach resources for cardiologists.
• Boehringer Ingelheim and Eli Lilly and CompanyminorOthersPharmaceutical alliance sponsor for SGLT2i algorithm development resources.
• Bayer Inc.minorOthersEducational grant provider for The New HFrontier webinar series on heart failure worsening and TTR amyloidosis.
• AlnylamminorOthersEducational grant provider for The New HFrontier webinar series on TTR amyloidosis.
• PfizerminorOthersEducational grant provider for The New HFrontier webinar series on TTR amyloidosis.
• Canadian Heart Function AlliancemajorStrategic or Co-development PartnerAlliance partner for heart failure awareness week and professional education resources.
• Association canadienne de prévention et de réadaptation cardiovasculaires (CACPR)majorStrategic or Co-development PartnerPartner for heart failure awareness week and professional education collaboration.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/canhfsociety
• YouTubeyoutube.com/channel/UCOCIicW1dNuxJfVOOxdC5JQ
• Facebookfacebook.com/canadianheartfailuresociety
• LinkedInlinkedin.com/company/canadianheartfailuresociety
• Instagraminstagram.com/canadianheartfailuresociety

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Canadian Heart Failure Society